India's drug regulator has granted restricted emergency use authorisation for Biological E's Covid vaccine Corbevax for those aged five to 12 years and Bharat Biotech's Covaxin for children in the age group of six to 12 years, Union Health minister Mansukh Mandaviya said on Tuesday.
The approval by the Drugs Controller General of India (DCGI) for Corbevax and Covaxin for inoculating children below 12 years paves the way for giving protection to a majority of school-going children and assumes significance ahead of Prime Minister Narendra Modi's meeting with chief ministers on the emerging Covid situation in the country on Wednesday through video conferencing.
The DCGI has also granted emergency use authorisation (EUA) to Cadila for its ZyCoV D for an additional dose of 3mg with a two-jab inoculation schedule 28 days apart for those aged above 12 years.
ZyCoV-D is, currently, approved for a 2mg three-dose vaccination schedule.
The DCGI approval comes following recommendations by the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO).
Denne historien er fra April 27, 2022-utgaven av Millennium Post Delhi.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra April 27, 2022-utgaven av Millennium Post Delhi.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
TOP 5 INDIAN SERIES YOU SHOULDN'T MISS
LOOKING BACK AT 2024
SENSE AND SENSIBILITY
There's a whole tribe out there who refuses to subscribe to resolutions
Sharad calls Sanjay Leela Bhansali a 'demanding director'
Filmmaker Sanjay Leela Bhansali is known for his attention to detail and fiery on-set personality. Sharad Kelkar, who played a negative role in Bhansali's 'Goliyon Ki Rasleela: Ram-Leela,' opened up about his experience of working with the director.
Shruti reflects on parents Kamal Haasan and Sarika's 'painful' divorce
When my parents split up, everything changed. That's when I realised the value of financial independence,' she says
Blake claims Justin's smear campaign gets support in publicist's suit
The lawsuit was lodged in Manhattan by Stephanie Jones
Indian star fined 20% match fees, one demerit point
KOHLI, KONSTAS FACE OFF AT MCG
Bumrah keeps battle alive; Aus score 311/6 after Konstas debut
JADEJA LEAKED RUNS DESPITE GETTING KONSTAS OUT
D-Street small stocks steal the show in 2024, giving handsome returns to investors
Market experts are optimistic about midcap & smallcap stocks for next year, driven by factors like strong domestic consumption & govt infra spending
Depreciation of rupee likely to push import bill by $15 billion, says GTRI
Compared to December last year, Rupee has depreciated 2.34% against dollar, moving from Rs 83.25 to Rs 85.20,
Sri Lanka seeks to boost foreign investments in its stocks market as debt worries fade
Colombo Stock Exchange plans to hold a conference in the national capital on March 27-28 to attract overseas investors
